Real - Time OneStep RT-PCR based assay system for detection of 2019-nCoV (CE-IVD)
The COVID-19 RT-PCRT est is a real-time reverse transcription polymerase chain reaction (rRT -PCR) test. The test can be run in a singleplex format (three individual assays) or multiplexed into a single reaction and amplification set up.
One-step real-time-PCR test for qualitative detection of genetic material of SARS-CoV-2 virus in upper and lower respiratory specimens collected from individuals suspected of COVID-19 infection. Targets the RdRp gene and E gene. Products with high specificity and sensitivity for accurate and reliable results.
RTPCR testing kits are used for testing golden test processes to detect Covid19 viruses in patients.
OSANG An established PCR test kit that has had exceptional results both in the lab and in real world settings with major countries reporting sensitivity results. The PCR is the first Korean test kit to receive FDA, EUA, and CE approval, allowing this test kit to be sold globally without restrictions. We are able to secure ample volume reliably.
Super long life refrigeration sheet modified by special process; Precision temperature control technology ensures that the temperature fluctuation of each hole is less than 0.1 ; Ultra high sensitivity PMT system combined with precision optical system ensures accuracy; New automatic hot cover technology can effectively prevent reagent evaporation; Maximum 6 channels fluorescence detection, no cross interference between channels; Intelligent operating system, flexible program setting, comprehensive analysis and report function;
The KAiRA 2019-nCoV PCR Detection Kit is a one step RT-PCR reagent system, based on real-time PCR technology, for the qualitative detection and differentiation of lineage B-beta Coronavirus and severe acute respiratory syndrome coronavirus 2 specific RNA. The test kit has FDA and CE Approval and comes in packs of 100 tests. In combination with Dr PCR the test results for PCR Testing can be given in under an hour and are compatible for use for international travel requirements. Unit - Kit (1 kit contains 100 tests) Unit Price - $900 per kit
CoVirion-CV19-2 SARS-CoV-2 OneStep RT-PCR kit is a probe-based Real Time PCR test designed for the qualitative detection of SARS-CoV-2 Coronavirus, the etiological agent of COVID-2019. It is used to detect N-gene and S-gene in viral RNA.
Cov-inu RT-PCR kit is a probe based Real Time PCR test designed for the qualitative de- tection of SARS-CoV-2 Coronavirus, the etiological agent of COVID-2019 and A + B Group Inuenza virus (orthomyxovirus). It is used to detect S- M2 ve NS1 genes in viral RNA. Description of the Kit Cov-inu RT PCR Kit is a multiplex PCR kit that is used for the simultaneous detection of COVID-19 agent SARS-COV-2 and Inuenza A and Inuenza B viruses from the same sample. Coronaviruses are a large family of viruses that cause infections in humans and other mammals (such as camels, cats, dogs, and bats). The SARS-CoV-2 virus is a new coronavirus that was identified by the World Health Organization (WHO) (1) on February 11, 2020. Inuenza is caused by three types of immunological RNA viruses (A, B and C) in the Orthomyxoviridae family. Seasonal inuenza is typically caused by three main hem- agglutinin subtypes (H1, H2, and H3) and two neuraminidase subtypes (N1 and N2). It is important that public health laboratories around the world conduct detailed surveillance to monitor the spread and impact of the pandemic H1N1 2009 virus, as well as predict future changes in virulence (4). Therefore, methods for rapid diagnosis, case detection and follow-up of this new pathogen in the human population are necessary to develop appropriate management strategies to reduce morbidity and mortality. The test works with single-stage real time reverse transcriptase polymerase chain reaction (On- eStep RT-PCR) with serum, lower respiratory tract samples (e.g. bronchoalveolar lavage, sputum, tracheal aspirate), and upper respiratory tract samples (e.g. nasopharyngeal uids, nasal swab) from individuals who demonstrate clinical criteria set for COVID-19 by WHO (2) and CDC (Center for Disease Control and Prevention) (3). This kit is an In-vitro diagnostic kit using specific primers designed for qualitative detection of genomic RNAs of SARS-CoV-2, Inuenza A and Inuenza B virus.
Real time PCR instrument. With 16-, 48-, or 96- wells. with 4-. 5-. or 6- channels.
Lowest detection line:200 copy/ml CE marks
It has CE certificate 25 test per box
25 tests per box
Intended Use Novel Coronavirus (2019-nCoV) Real-time RT-PCR Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the 2019-nCoV in oropharyngeal swabs and bronchoalveolar lavage fluid collected form individuals suspected of COVID-19 by their healthcare provider. About SARS-CoV-2 Specific antibodies will be produced within days to weeks as the immune system makes immune defense against the SARS-CoV-2 infection. Total antibody detection is an aid in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with clinical symptoms and result of other diagnostic methods. The test result should not be used as the sole basis for diagnosis and exclusion of SARS-CoV-2 infection. Total antibody may not be detected in the first few days of infection. SARS-CoV-2 neutralizing antibody is a protective soluble protein secreted by adaptive immunizing cells after inoculation with SARS-CoV-2 vaccine or infection with SARS-CoV-2. These antibodies can specific bind with virus RNA binding domain (RBD) to block the binding of RBD with angiotensin-converting enzyme 2 (ACE2) on human cells surface, thus prevent the virus or its genetic material into the human cell and virus infection. Benifits of the Kit 1) Room Temperature Transportation 2) Cost-Effective Shipping The shipping is at room temperature, with no need of cold chain shipping. 3) Highly Sensitive, Highly Specific Highly sensitive and highly specific for 2019-nCoV, reliable identification of COVID-19. 4) Environmentally Friendly The kit needs neither bulky packaging nor cold chain shipping. Contents A kit contains: Package specifications: 24 tests/kit, 48 tests/kit 1) 2019-nCoV-PCR Master Mix (Lyophilized Powder): 1 bottle/box 2) 2019-nCoV-PCR Positive Control (Lyophilized Powder):1 bottle/box 3) 2019-nCoV Diluent: 1 bottle/box 4) User Manual Note: Do not mix or interchange different batches of kits.
HPV is a virus that causes papillomas (benign tumors), and about 200 types have been discovered so far. Some types of HPV are known to be the direct cause of cervical cancer, head and neck cancer, etc. In particular, in the case of cervical cancer, more than 99% of the causes are reported to be caused by HPV. If it is detected early, it is easy to treat, but if it is detected late, the 5-year survival rate is less than 15% even with treatment, so regular check-ups are very important. SML Genetree has developed the world's first Ezplex�® HPV NGS Kit to diagnose HPV using the NGS method. Unlike the existing methods that only detected up to 20 to 40 types and only positive-negative, NGS was introduced to provide positive results for 45 types of HPV (up to 100 types including for export) according to the amount of DNA detected in steps 1 to 3 Semi-quantitative inspection of the level is possible. It has a high level of automation that is close to full automatic. The time has been shortened so that up to 480 people can be analyzed within 16 hours with one analysis, and it is possible to distinguish HPV species that were difficult to distinguish precisely. Unlike the existing sequencing method, the NGS method has been highly evaluated for its potential as a precision medical technology that can dramatically reduce time and cost by analyzing numerous DNAs at high speed. As a result of clinical efficacy evaluation with more than 2500 clinical specimens in large domestic hospitals, it is a product with high sensitivity and specificity compared to existing tests.
Ezplex�® SARS-CoV-2 G Kit, developed by SML Genetree, is a product that has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). This is an in vitro diagnostic test that qualitatively detects the nucleic acids of SARS-CoV-2 (RdRp and N genes) in sputum to aid in emergency screening for COVID-19. This product can be used for a large amount of screening tests because it can perform a pooling test, unlike the products that the existing domestic companies have approved for emergency use by the FDA. For the combined test, samples are collected in units of 5 people and tested. If positive, individual tests are performed. In the case of a negative test, all tests are performed in a negative way. In particular, since a large number of samples are tested at once, the test is only possible with high sensitivity and specificity compared to existing diagnostic kits. According to the FDA, it was confirmed that 100% agreement was achieved in the result comparison test of individual and collective tests, and it was the 20th in the world and the first Korean company to pass the test. Excellent clinical performance was demonstrated by confirming high sensitivity and specificity through clinical evaluation, and stability was confirmed for 12 months through long-term storage tests. In January 2021, it was officially approved by the Korean Ministry of Food and Drug Safety (MFDS).
Ezplex MTBC/NTM Real-time PCR Kit is an in vitro diagnostic test that simultaneously detects Mycobacterium tuberculosis complex (MTBC) and 20 types of nontuberculous mycobacteria (NTM). Sensitivity : Multiple gene targets for MTBC and NTM. Clinical Performance: Validated clinical performance. Fast Results: Testing can be completed within 2 hours post extraction.
Ezplex Respiratory Pathogens Real-time PCR Kit is an in vitro diagnostic test for the qualitative detection of 19 respiratory viruses and 6 types of pneumonia-causing bacteria through nucleic acids isolated and extracted from human throat swabs using real-time polymerase chain reaction Comprehensive Panel- One test can identify 19 respiratory viruses and 6 bacterial species simultaneously. Sensitivity Detection of all targeted viruses and bacteria with high sensitivity. Convenience Genetree Viewer analysis software available for users to conveniently produce test results. Clinical Performance: Clinical testing confirmed the high sensitivity and specificity. Stability: Shelf life of up to 12 months. Analytical Specificity: Testing of 31 species of microorganisms showed no cross reactivity.
Ezple Respiratory Pathogens Real-time PCR Kit is an in vitro diagnostic test for the qualitative detection of 19 respiratory viruses and 6 types of pneumonia-causing bacteria through nucleic acids isolated and extracted from human throat swabs using real-time polymerase chain reaction.
MTBC/NTM Real-time PCR Kit is an in vitro diagnostic test that simultaneously detects Mycobacterium tuberculosis complex (MTBC) and 20 types of nontuberculous mycobacteria (NTM).
